The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Patterns in cancer management changes for patients with COVID-19 in northern California.
 
Michael Glover
No Relationships to Disclose
 
Julie Wu
No Relationships to Disclose
 
Daniel H Kwon
Stock and Other Ownership Interests - Invitae
 
Sylvia Zhang
No Relationships to Disclose
 
Solomon Henry
Stock and Other Ownership Interests - Pfizer
 
Douglas Wood
No Relationships to Disclose
 
Daniel Rubin
Consulting or Advisory Role - Roche/Genentech
Research Funding - GE Healthcare (Inst); Philips Healthcare (Inst)
Patents, Royalties, Other Intellectual Property - Several pending patents on AI algorithms (Inst)
 
Hala Borno
Employment - Collective Health (I)
Leadership - Collective Health (I)
Stock and Other Ownership Interests - Collective Health (I)
Honoraria - BMS; Dendreon
Consulting or Advisory Role - BMS; Dendreon
 
Eric Jay Small
Stock and Other Ownership Interests - Fortis; Harpoon Therapeutics
Honoraria - Janssen; Johnson and Johnson
Consulting or Advisory Role - Beigene; Fortis; Fortis; Janssen Oncology; Teon Therapeutics; Tolero Pharmaceuticals; Ultragenyx Pharmaceuticals
Research Funding - Janssen (Inst)
Travel, Accommodations, Expenses - Janssen
 
Lidia Schapira
Consulting or Advisory Role - Blue Note Therapeutics; Rubedo Life Sciences
 
Vadim S Koshkin
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Dendreon; Gerson Lehrman Group; Guidepoint Global; Janssen; Pfizer/EMD Serono; Seattle Genetics/Astellas
Speakers' Bureau - Seattle Genetics/Astellas
Research Funding - Clovis Oncology; Endocyte; Janssen Oncology; Nektar
Travel, Accommodations, Expenses - AstraZeneca; Janssen
 
Sumit Shah
Stock and Other Ownership Interests - Grand Rounds
Honoraria - Janssen
Consulting or Advisory Role - Natera
Research Funding - Genentech